These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 37181684)

  • 21. Overlapping Delta and Omicron Outbreaks During the COVID-19 Pandemic: Dynamic Panel Data Estimates.
    Lundberg AL; Lorenzo-Redondo R; Hultquist JF; Hawkins CA; Ozer EA; Welch SB; Prasad PVV; Achenbach CJ; White JI; Oehmke JF; Murphy RL; Havey RJ; Post LA
    JMIR Public Health Surveill; 2022 Jun; 8(6):e37377. PubMed ID: 35500140
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The association of community mobility with the time-varying reproduction number (R) of SARS-CoV-2: a modelling study across 330 local UK authorities.
    Li Y; Wang X; Campbell H; Nair H;
    Lancet Digit Health; 2021 Oct; 3(10):e676-e683. PubMed ID: 34479825
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Assessing the feasibility of sustaining SARS-CoV-2 local containment in China in the era of highly transmissible variants.
    Wang Y; Sun K; Feng Z; Yi L; Wu Y; Liu H; Wang Q; Ajelli M; Viboud C; Yu H
    BMC Med; 2022 Nov; 20(1):442. PubMed ID: 36380354
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Assessing the nationwide impact of COVID-19 mitigation policies on the transmission rate of SARS-CoV-2 in Brazil.
    Jorge DCP; Rodrigues MS; Silva MS; Cardim LL; da Silva NB; Silveira IH; Silva VAF; Pereira FAC; de Azevedo AR; Amad AAS; Pinho STR; Andrade RFS; Ramos PIP; Oliveira JF
    Epidemics; 2021 Jun; 35():100465. PubMed ID: 33984687
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Movement restrictions, vaccine coverage, and reduction of the COVID-19 incidence rate in the fourth wave of the pandemic: Analysis results from 63 provinces in Vietnam.
    Bui HM; Ha MH; Dao TP; Vu MD; Pham TQ; Nguyen ML; Phan MH; Nguyen MTT; Hoang XHT; Ngo HTT; Van MD; Quang CL
    Front Public Health; 2022; 10():988107. PubMed ID: 36711402
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impact of Governmental interventions on epidemic progression and workplace activity during the COVID-19 outbreak.
    Ram SK; Sornette D
    Sci Rep; 2021 Nov; 11(1):21939. PubMed ID: 34753988
    [TBL] [Abstract][Full Text] [Related]  

  • 27. SARS-CoV-2 B.1.1.529 (Omicron) Variant - United States, December 1-8, 2021.
    CDC COVID-19 Response Team
    MMWR Morb Mortal Wkly Rep; 2021 Dec; 70(50):1731-1734. PubMed ID: 34914670
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Substantial impact of mobility restrictions on reducing COVID-19 incidence in Italy in 2020.
    Vinceti M; Balboni E; Rothman KJ; Teggi S; Bellino S; Pezzotti P; Ferrari F; Orsini N; Filippini T
    J Travel Med; 2022 Sep; 29(6):. PubMed ID: 35876268
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Performance of the Swiss Digital Contact-Tracing App Over Various SARS-CoV-2 Pandemic Waves: Repeated Cross-sectional Analyses.
    Daniore P; Nittas V; Ballouz T; Menges D; Moser A; Höglinger M; Villiger P; Schmitz-Grosz K; Von Wyl V
    JMIR Public Health Surveill; 2022 Nov; 8(11):e41004. PubMed ID: 36219833
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Epidemiological characteristics and transmission dynamics of the outbreak caused by the SARS-CoV-2 Omicron variant in Shanghai, China: a descriptive study.
    Chen Z; Deng X; Fang L; Sun K; Wu Y; Che T; Zou J; Cai J; Liu H; Wang Y; Wang T; Tian Y; Zheng N; Yan X; Sun R; Xu X; Zhou X; Ge S; Liang Y; Yi L; Yang J; Zhang J; Ajelli M; Yu H
    medRxiv; 2022 Jun; ():. PubMed ID: 35765564
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effectiveness of COVID-19 vaccines against SARS-CoV-2 Omicron variants during two outbreaks from March to May 2022 in Quzhou, China.
    Yin Z; Fang Q; Wen T; Zheng C; Fu C; Wang S; Li J; Gong X
    Hum Vaccin Immunother; 2023 Dec; 19(1):2163813. PubMed ID: 36704960
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Nova Scotia Strong: why communities joined to embrace COVID-19 public health measures.
    Steenbeek A; Gallant A; MacDonald NE; Curran J; Graham JE
    Can J Public Health; 2022 Dec; 113(Suppl 1):4-13. PubMed ID: 35882714
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Effect of Governmental Health Measures on Public Behaviour During the COVID-19 Pandemic Outbreak.
    Wang G; Li L; Wang L; Xu Z
    Int J Health Policy Manag; 2022 Oct; 11(10):2166-2174. PubMed ID: 34814663
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The impact of public transportation on the transmission of COVID-19 in Rwanda.
    Umutoni B; Tumushime JC; Hewins B; Udahemuka JC; Ndishimye P; Kelvin DJ; Sganzerla Martinez G
    Front Public Health; 2024; 12():1345433. PubMed ID: 38476489
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Facing the Omicron variant-how well do vaccines protect against mild and severe COVID-19? Third interim analysis of a living systematic review.
    Külper-Schiek W; Piechotta V; Pilic A; Batke M; Dreveton LS; Geurts B; Koch J; Köppe S; Treskova M; Vygen-Bonnet S; Waize M; Wichmann O; Harder T
    Front Immunol; 2022; 13():940562. PubMed ID: 36091023
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Is the SARS CoV-2 Omicron Variant Deadlier and More Transmissible Than Delta Variant?
    Duong BV; Larpruenrudee P; Fang T; Hossain SI; Saha SC; Gu Y; Islam MS
    Int J Environ Res Public Health; 2022 Apr; 19(8):. PubMed ID: 35457468
    [TBL] [Abstract][Full Text] [Related]  

  • 37. COVID-19 pandemic dynamics in India, the SARS-CoV-2 Delta variant, and implications for vaccination.
    Yang W; Shaman J
    medRxiv; 2021 Nov; ():. PubMed ID: 34845460
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Vaccine effectiveness against SARS-CoV-2 reinfection during periods of Alpha, Delta, or Omicron dominance: A Danish nationwide study.
    Nielsen KF; Moustsen-Helms IR; Schelde AB; Gram MA; Emborg HD; Nielsen J; Hansen CH; Andersen MA; Meaidi M; Wohlfahrt J; Valentiner-Branth P
    PLoS Med; 2022 Nov; 19(11):e1004037. PubMed ID: 36413551
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lockdowns result in changes in human mobility which may impact the epidemiologic dynamics of SARS-CoV-2.
    Kishore N; Kahn R; Martinez PP; De Salazar PM; Mahmud AS; Buckee CO
    Sci Rep; 2021 Mar; 11(1):6995. PubMed ID: 33772076
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Perceptions of Covid-19 lockdowns and related public health measures in Austria: a longitudinal online survey.
    Łaszewska A; Helter T; Simon J
    BMC Public Health; 2021 Aug; 21(1):1502. PubMed ID: 34344343
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.